Arkolith/Insider Trading/RLMD/Form 4

Traversa Sergio

Chief Executive Officer, DirectorRELMADA THERAPEUTICS, INC. (RLMD) · full profile →Form 4 · filed Dec 12, 2022
Net Buying
Open-Market Buys
$116K
Open-Market Sells
$0
Net Open-Market Flow
$116K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 8, 2022Buy(P)55K$2.10$116K144K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-22-079244) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML